Cadila Healthcare gets DCGI nod to conduct phase III trials for two-dose Covid vaccine

Cadila Healthcare gets DCGI nod to conduct phase III trials for two-dose Covid vaccine The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20. https://ift.tt/eA8V8J